Wells Fargo & Company Kamada LTD Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Kamada LTD stock. As of the latest transaction made, Wells Fargo & Company holds 608,590 shares of KMDA stock, worth $4.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
608,590
Previous 630,688
3.5%
Holding current value
$4.65 Million
Previous $3.84 Million
4.74%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding KMDA
# of Institutions
39Shares Held
5.03MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$12.6 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$6.18 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.42 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.52 Million0.19% of portfolio
-
Acadian Asset Management LLC Boston, MA256KShares$1.95 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $342M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...